Providing the highest standard of care for ADHD patients is at the core of clinicians’ goals. However, without…
Blog
Blog
Is ADHD on the rise? What the latest data tells us
There’s been a noticeable rise in media and public interest in ADHD in recent years. A 2024 YouGov…
QbCheck’s tech-forward care enhances clinician confidence for US virtual care provider
Key takeaways: With QbCheck, clinicians can diagnose ADHD longitudinally over 2 visits, after a complete data review. Since…
What the NHS ADHD Taskforce report means for clinicians
Summary – What clinicians need to know The NHS England ADHD Taskforce has released its Interim Report on…
DSM-5 and ADHD: What changed, what’s missing, and what clinicians must know
The Diagnostic and Statistical Manual of Mental Disorders (DSM) was first introduced in the 1950s. It went through…
UK’s largest virtual healthcare service providing consistent high-quality ADHD care with QbCheck
ADHD 360 is the UK’s largest virtual healthcare service specializing in ADHD diagnosis and treatment. Its primary goal…
What does the gold standard of ADHD diagnosis and treatment look like in 2025 and beyond?
In 2025, the gold standard of ADHD diagnosis and treatment is evolving, shaped by updated DSM-5 criteria, new…
CHIRP model’s objective technology (QbCheck) improves ADHD pathway efficiency in New Zealand (2023)
QbCheck’s objective ADHD testing solutions land in New Zealand. The CHIRP model (combining paediatrics, child development services and…
QbCheck as an objective measure of ADHD symptoms to ensure optimal medical treatment in a pediatric(0-17y) population (2023)
The CHIRP model (combining paediatrics, child development services and child and adolescent mental health) came into effect in…
Remote objective ADHD assessment to monitor treatment effects as part of UK-based virtual healthcare service, ADHD 360 (2025)
The present study examines the implementation of QbCheck within a remote care framework, with particular focus on its…
